Market Overview:
The global retropharyngeal abscess treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of retropharyngeal abscesses, rising awareness about available treatments, and growing demand for minimally invasive procedures. The global retropharyngeal abscess treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibiotics, pain killers, surgical drainage, and others.
Product Definition:
Retropharyngeal abscess treatment is the process of clearing an infection that has developed in the space behind the throat. Treatment may include antibiotics, drainage of the abscess, and/or surgery. Retropharyngeal abscesses can be dangerous if they are not treated promptly, as they can cause difficulty breathing and even death.
Antibiotics:
Antibiotics Market is expected to grow at a CAGR of XX% during the forecast period. The market growth can be attributed to factors such as increasing geriatric population, rising prevalence of chronic diseases and changing lifestyle. Antibiotics are used for treatment against bacterial infection in various parts of the body including skin, lungs, urinary tract and others. Bacterial infections are primarily treated with antibiotics however some viral infections as well as certain parasitic infections may also respond to antibiotics treatment.
Pain Killers:
Painkillers are drugs that block the transmission of pain signals to the brain. They can be used for acute as well as chronic pain. The most commonly used medications include aspirin, acetaminophen (Paracetamol), and ibuprofen (Advil, Motrin). Other medications such as hydrocodone bitartrate (Lortab) and codeine are also widely used but have a lower prevalence in comparison with other two aforementioned groups of drugs.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and others. Hospitals held the largest share of over 70% in 2017. Retropharyngeal abscesses occur most commonly in patients who have undergone general anesthesia for surgical procedures or dental treatments. These patients often suffer from other conditions such as obesity which increases the risk of developing retropharyngeal space infection (rSI). Hospitals are thus expected to be one of the prominent segments driving growth during forecast years due to rising incidence rates coupled with increasing awareness about early diagnosis and treatment options for retropharyngeal space infections (rSI).
The clinics segment is anticipated to witness significant growth during forecast years owing to an increase in demand for minimally invasive procedures leading to a rise in number of treated cases at outpatient facilities or secondary care settings.
Regional Analysis:
North America dominated the global retropharyngeal abscess treatment market in 2017. This can be attributed to increasing incidence of cancer, rising awareness about early diagnosis, and availability of effective treatment methods for this condition. In addition, presence of key players in this region is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness fastest growth during the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness levels regarding available treatments for retropharyngeal abscesses. Moreover, increase in number of surgeries due to rising incidences of cancer will also support regional demand during the same period (2018-2030).
Growth Factors:
- Increasing incidence of retropharyngeal abscesses
- Rising demand for minimally invasive procedures
- Growing number of surgical procedures performed in hospitals and ambulatory surgery centers
- Technological advancements in retropharyngeal abscess treatment devices and therapies
- Rising awareness about the benefits of early diagnosis and treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Retropharyngeal Abscess Treatment Market Research Report
By Type
Antibiotics, Pain Killers, Surgical Drainage, Others
By Application
Hospitals, Clinics, Others
By Companies
Pfizer, Sanofi, Novartis, Johnson & Johnson, GlaxoSmithKline, Merck, AstraZeneca, Mylan, Teva pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Retropharyngeal Abscess Treatment Market Report Segments:
The global Retropharyngeal Abscess Treatment market is segmented on the basis of:
Types
Antibiotics, Pain Killers, Surgical Drainage, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Sanofi
- Novartis
- Johnson & Johnson
- GlaxoSmithKline
- Merck
- AstraZeneca
- Mylan
- Teva pharmaceutical
Highlights of The Retropharyngeal Abscess Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Pain Killers
- Surgical Drainage
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Retropharyngeal Abscess Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Retropharyngeal abscess is a type of infection that occurs in the space behind the throat (retropharynx). The retropharynx is located between the pharynx and laryngophagus. Retropharyngeal abscesses are most commonly caused by bacteria, but can also be caused by viruses.nnThe treatment for retropharyngeal abscess depends on the cause. If it is due to bacteria, antibiotics may be prescribed. If it is due to a virus, antiviral medication may be recommended.
Some of the key players operating in the retropharyngeal abscess treatment market are Pfizer, Sanofi, Novartis, Johnson & Johnson, GlaxoSmithKline, Merck, AstraZeneca, Mylan, Teva pharmaceutical.
The retropharyngeal abscess treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Retropharyngeal Abscess Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Retropharyngeal Abscess Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Retropharyngeal Abscess Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Retropharyngeal Abscess Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Retropharyngeal Abscess Treatment Market Size & Forecast, 2018-2028
4.5.1 Retropharyngeal Abscess Treatment Market Size and Y-o-Y Growth
4.5.2 Retropharyngeal Abscess Treatment Market Absolute $ Opportunity
Chapter 5 Global Retropharyngeal Abscess Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Retropharyngeal Abscess Treatment Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Pain Killers
5.2.3 Surgical Drainage
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Retropharyngeal Abscess Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Retropharyngeal Abscess Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Retropharyngeal Abscess Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Retropharyngeal Abscess Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Retropharyngeal Abscess Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Retropharyngeal Abscess Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Retropharyngeal Abscess Treatment Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Pain Killers
9.6.3 Surgical Drainage
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Retropharyngeal Abscess Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Retropharyngeal Abscess Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Retropharyngeal Abscess Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Retropharyngeal Abscess Treatment Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Pain Killers
10.6.3 Surgical Drainage
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Retropharyngeal Abscess Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Retropharyngeal Abscess Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Retropharyngeal Abscess Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Retropharyngeal Abscess Treatment Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Pain Killers
11.6.3 Surgical Drainage
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Retropharyngeal Abscess Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Retropharyngeal Abscess Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Retropharyngeal Abscess Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Retropharyngeal Abscess Treatment Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Pain Killers
12.6.3 Surgical Drainage
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Retropharyngeal Abscess Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Retropharyngeal Abscess Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Retropharyngeal Abscess Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Retropharyngeal Abscess Treatment Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Pain Killers
13.6.3 Surgical Drainage
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Retropharyngeal Abscess Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Retropharyngeal Abscess Treatment Market: Competitive Dashboard
14.2 Global Retropharyngeal Abscess Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Sanofi
14.3.3 Novartis
14.3.4 Johnson & Johnson
14.3.5 GlaxoSmithKline
14.3.6 Merck
14.3.7 AstraZeneca
14.3.8 Mylan
14.3.9 Teva pharmaceutical
